Board of Directors
Members of our Board of Directors include:
Peter Barrett, Chair
Senior Partner in the Life Sciences sector, Atlas Ventures
Former co-founder and Executive Vice President, Celera Genomics
Alan Crane, Vice Chair
Founder and Chief Executive Officer, Cerulean Pharaceuticals
Former CEO, Momenta Pharmaceuticals
Former Senior Vice President, Corporate Development, Millennium Pharmaceuticals
Janet Atkins, Treasurer
Principal of Ridgeway Advisors
John Graham, Secretary
Partner, Sullivan Worcester
Paul Marcus
President, Davis Marcus Partners
Edward Scolnick, MD
Director, Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard
Former President of Merck Research Laboratories
James F. Gusella*, PhD
Senior Science Advisor, Autism Consortium
Chair, Steering Committee, Autism Consortium
Director, Center for Human Genetic Research, Massachusetts General Hospital
Deirdre B. Phillips*
Cheif Strategy Officer, Autism Consortium
Mriganka Sur*, PhD
Department Chair of Brain and Cognitive Sciences, Massachusetts Institute of Technology
Tish Tanski*, MSW
Executive Director, Autism Consortium
Christopher Walsh*, MD, PhD
Chair, Scientific Advisory Board, Autism Consortium
Chief, Division of Genetics, Children’s Hospital
* Indicates Non-Voting Member
